Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-07

Clinical Trial Update: T Cell Vaccination in Patients With Progressive Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Completion of Phase 1/2 trials evaluating a T cell vaccination approach for progressive multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • T cell vaccine (T cell vaccination)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED